Invention Grant
- Patent Title: Antineoplastic peptides
- Patent Title (中): 抗肿瘤肽
-
Application No.: US12079980Application Date: 2008-03-31
-
Publication No.: US07807779B2Publication Date: 2010-10-05
- Inventor: Wilhelm Amberg , Teresa Barlozzari , Harald Bernard , Ernst Buschmann , Andreas Haupt , Hans-Guenther Hege , Bernd Janssen , Andreas Kling , Helmut Lietz , Kurt Ritter , Martina Ullrich , Jurgen Weymann , Thomas Zierke
- Applicant: Wilhelm Amberg , Teresa Barlozzari , Harald Bernard , Ernst Buschmann , Andreas Haupt , Hans-Guenther Hege , Bernd Janssen , Andreas Kling , Helmut Lietz , Kurt Ritter , Martina Ullrich , Jurgen Weymann , Thomas Zierke
- Applicant Address: DE Wiesbaden
- Assignee: Abbott GmbH & Co. KG
- Current Assignee: Abbott GmbH & Co. KG
- Current Assignee Address: DE Wiesbaden
- Agency: Lahive & Cockfield, LLP
- Agent Giulio A. DeConti, Jr.; Brian C. Trinque
- Main IPC: C07K7/00
- IPC: C07K7/00 ; A61K38/00
Abstract:
The present invention provides antineoplastic peptides of formula I, R1R2N—CHX—CO—A—B-D-E-(G)s-K wherein R1, R2, X, A, B, D, E, G, K and s have the meanings stated in the description. The compounds have antineoplastic activity.
Public/Granted literature
- US20080234205A1 Antineoplastic peptides Public/Granted day:2008-09-25
Information query
